NTHI Stock: Price, Forecast, Financials & AI Analysis

High

Open

VWAP

Vol

Mkt Cap

Low

Amount

EV/EBITDA(TTM)

Total Shares

EV/OCF(TTM)

P/S(TTM)

Valuation Metrics

The current forward P/E ratio for NeOnc Technologies Holdings Inc (NTHI.O) is 0.00, compared to its 5-year average forward P/E of 0.00. For a more detailed relative valuation and DCF analysis to assess NeOnc Technologies Holdings Inc 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

0.00

Current PE

0.00

Overvalued PE

0.00

Undervalued PE

0.00

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

0.00

Current EV/EBITDA

0.00

Overvalued EV/EBITDA

0.00

Undervalued EV/EBITDA

0.00

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

N/A

5Y Average PS

0.00

Current PS

0.00

Overvalued PS

0.00

Undervalued PS

0.00

Financials

Annual

Quarterly

N/A

Total Revenue

N/A

Operating Profit

N/A

Net Income after Tax

N/A

EPS - Diluted

N/A

Gross Profit Margin - %

N/A

Net Margin - %

Trading Trends

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Hedge Fund

Hedge Funds are Neutral. There are no significant trading trends over the last quarter.

Sold

Bought

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

NTHI News & Events

Events Timeline

No data

News

9.0

12-15Newsfilter

PinnedNeOnc Technologies Reports 24% Radiographic Response with NEO100 in CNS Cancer Trials

9.0

12-15Globenewswire

NeOnc's NEO100 Therapy Significantly Increases Survival Rates

3.5

12-01Newsfilter

NeOnc Technologies' NEO100 Therapy Shows Significant Antitumor Enhancement with Ultrasound

People Also Watch

Frequently Asked Questions

What is NeOnc Technologies Holdings Inc (NTHI) stock price today?

The current price of NTHI is 9.69 USD — it has decreased -3.34 % in the last trading day.

What is NeOnc Technologies Holdings Inc (NTHI)'s business?

NeOnc Technologies Holdings, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on establishing treatments for intracranial malignancies, such as aggressive cancers located in the brain. It is the developer of a novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. It is developing novel drug delivery methods to be used in combination with novel drug candidates. The Company has two lead products in development: NEO100 and NEO212. NEO100 is a purified form of perillyl acid (POH) which is administered to brain cancer patients via intranasal delivery. NEO212 is a covalently conjugated molecule combining the chemotherapeutic drug temozolomide with perillyl alcohol. NEO212 is undergoing development towards intranasal application specifically for patients with uncontrolled brain metastases derived from peripheral tumors (lung, breast, skin, and others).

What is the price predicton of NTHI Stock?

Wall Street analysts forecast NTHI stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for NTHI is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is NeOnc Technologies Holdings Inc (NTHI)'s revenue for the last quarter?

NeOnc Technologies Holdings Inc revenue for the last quarter amounts to 0.00 USD, decreased % YoY.

What is NeOnc Technologies Holdings Inc (NTHI)'s earnings per share (EPS) for the last quarter?

NeOnc Technologies Holdings Inc. EPS for the last quarter amounts to -0.45 USD, increased 275.00 % YoY.

What changes have occurred in the market's expectations for NeOnc Technologies Holdings Inc (NTHI)'s fundamentals?

The market is revising No Change the revenue expectations for NTHI for , with the revenue forecasts being adjusted by % over the past three months. During the same period, the stock price has changed by -2.56%.

How many employees does NeOnc Technologies Holdings Inc (NTHI). have?

NeOnc Technologies Holdings Inc (NTHI) has 3 emplpoyees as of December 16 2025.

What is NeOnc Technologies Holdings Inc (NTHI) market cap?

Today NTHI has the market capitalization of 192.41M USD.